arrow
H

Hideki Furuya

cedars-sinai medical center
H指数:27
被引数:2,341

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

l-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: an open-label, single-arm, phase 1 GlutaPanc trial
2026-08-310
OAAI
Prospective multicenter validation of a Urine-Based multiplex assay for risk stratification of patients presenting with gross hematuria

基于尿液的多重检测方法在评估肉眼血尿患者风险分层中的多中心前瞻性验证

2026-08-170
OAAI
Development and validation of a tumor-derived CXCL1 qPCR assay to support patient selection for anti-CXCL1 therapeutics in bladder cancer

开发并验证一种肿瘤来源的CXCL1 qPCR检测方法,以支持膀胱癌患者选择抗CXCL1治疗药物

2026-05-230
OAAI
Detection of bladder cancer in patients with microscopic hematuria using Oncuria-Detect: results of a prospective, multicenter international study

使用Oncuria-Detect检测显微镜下血尿患者的膀胱癌:一项前瞻性、多中心国际研究的结果

2026-05-090
OA
APPLICATION OF TRANSCRIPTOMIC BLADDER-CANCER SUBTYPES TO UPPER-TRACT UROTHELIAL CARCINOMA (UTUC) ACROSS INTERNATIONAL COHORTS REVEALS RACIAL DIFFERENCES AND TRANSLATIONAL LIMITATIONS

转录组膀胱癌亚型应用于国际队列中的上尿路尿路上皮癌(UTUC)揭示了种族差异和转化局限性

2026-05-010
PRE
DETECTION OF BLADDER CANCER IN PATIENTS WITH GROSS HEMATURIA USING ONCURIA-DETECT, A URINE-BASED MULTIPLEX IMMUNOASSAY

使用尿基多重免疫检测试剂 ONCURIA-DETECT 检测肉眼血尿患者的膀胱癌

2026-05-010
PRE
DETECTION OF BLADDER CANCER IN PATIENTS WITH MICROSCOPIC HEMATURIA USING ONCURIA-DETECT, INTERIM ANALYSIS OF AN INTERNATIONAL PROSPECTIVE STUDY

使用Oncuria-Detect检测显微镜下血尿患者的膀胱癌:一项国际前瞻性研究的阶段性分析

2026-05-010
PRE
Development and analytical validation of a multiplex diagnostic qPCR-array as a potential application in predicting the response to neoadjuvant chemotherapy in muscle invasive bladder cancer

一种多重诊断qPCR阵列的开发与分析验证:作为预测肌肉浸润性膀胱癌新辅助化疗反应的潜在应用

2025-09-090
PREAI
Clinical relevance of Nectin-4 downregulation and biological changes caused by cytotoxic chemotherapy in bladder cancer

Nectin-4下调的临床意义以及细胞毒性化疗在膀胱癌中引起的生物学变化

2025-06-250
PRE
Performance of the Oncuria-Detect bladder cancer test for evaluating patients presenting with haematuria: results from a real-world clinical setting

Oncuria-Detect膀胱癌检测在评估出现血尿患者中的表现:来自真实世界临床环境的结果

2025-06-180
OAAI
An open label phase II study of lenvatinib with pembrolizumab and FLOT in the neoadjuvant and adjuvant treatment for patients with gastric and gastroesophageal junction adenocarcinoma (EPOC2001)

一项开放标签II期研究,评估lenvatinib联合pembrolizumab和FLOT在胃及胃食管结合部腺癌患者新辅助及辅助治疗中的应用(EPOC2001)。

2024-09-011
PRE
Comparison of Effective Imaging Modalities for Detecting Gastric Neoplasms: A Randomized 3-Arm Phase II Trial

检测胃肿瘤的有效成像方式的比较: 一项随机三臂II期试验

2024-05-162
OAAI
Biomarker analysis of pembrolizumab and ramucirumab neoadjuvant therapy for PD-L1-positive stage IB- IIIA lung cancer: EAST ENERGY trial
2024-03-220
PRE